Article: GE MONEY REACHES AGREEMENT WITH UNICREDIT ON BPH.

Article: GE Money Reaches Agreement with UniCredit on ...
Business Wire;  August 3, 2007 ;     700+ words ... ... of the agreement, GE Money will acquire close ... of the shares of New BPH from UniCredit ... this transaction, GE Money will have access to New BPH's universal banking ... around 200 branches. New BPH and GE Money's existing business ...

Article: New BPH combo therapy granted approval
Drug Topics;  July 14, 2008 ;     306 words ...Combination treatment with the alpha blocker tamsulosin (Flomax, Boehringer Ingelheim) and 5-alpha reductase inhibitor dutasteride (Avodart, GSK) has received approval for a new indication: treatment of symptomatic enlarged prostate or benign prostatic hyperplasia (BPH). The approval was based on

Article: GlaxoSmithKline Announces New BPH Trial to Examine ...
PR Newswire;  December 15, 2003 ;     700+ words ...GlaxoSmithKline today announced the initiation of a new international clinical trial evaluating dutasteride, a dual 5 alpha-reductase inhibitor (5 A-RI), in combination with the most widely prescribed alpha-blocker, tamsulosin, in men with benign prostatic hyperplasia (BPH). The COMBAT (Combination

Article: Nymox Announces New BPH Drug Long Term Follow-up ...
Business Wire;  October 11, 2007 ;     700+ words ...HASBROUCK HEIGHTS, N.J. -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) today announced that new follow-up study clinical trial data from the Company's studies of NX-1207 for benign prostatic hyperplasia (BPH) will be presented at the Mid-Atlantic Section of the American Urological Association

Article: TherMatrx Receives FDA Approval for New BPH ...
PR Newswire;  July 3, 2001 ;     700+ words ...SALT LAKE CITY, July 3 /PRNewswire/ -- BSD Medical Corp. (OTC Bulletin Board: BSDM) announced today that TherMatrx, Inc., in which it has 30% ownership, has received FDA approval to begin marketing its TMx-2000(TM) transurethral microwave thermotherapy system for treating benign prostatic

Article: Laserscope(R) To Launch Revolutionary New BPH ...
PR Newswire;  May 18, 2006 ;     700+ words ...New High Power Diode-Pumped GreenLight(TM) Multi-Application Laser Platform Leads Introduction of Five New Urology Products SAN JOSE, Calif., May 18 /PRNewswire-FirstCall/ -- Laserscope , a leader in the development and commercialization of minimally-invasive medical lasers and advanced fiber-optic

Article: Nymox Announces Clinical Study Presentation on New ...
Business Wire;  October 24, 2007 ;     700+ words ...HASBROUCK HEIGHTS, N.J. -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) today announced that clinical trial data from the Company's long term studies of NX-1207 for benign prostatic hyperplasia (BPH) will be presented at the Western Section of the American Urological Association Meeting in